The role of CTLA-4 in the regulation of T cell immune responses

被引:193
作者
McCoy, KD [1 ]
Le Gros, G [1 ]
机构
[1] Wellington Sch Med, Malaghan Inst Med Res, Wellington S, New Zealand
关键词
CD28; costimulation; CTLA-4; immune regulation; T lymphocyte;
D O I
10.1046/j.1440-1711.1999.00795.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the past few years a great deal of research has examined how T cell-dependent immune responses are initiated and subsequently regulated. Ligation of the TCR with an antigenic peptide bound to an MHC protein on a professional APC provides the crucial antigen-specific stimulus required for T cell activation. Interaction of CD28 with CD80 or CD86 molecules on APC initiates a costimulatory or second signal within the T cell which augments and sustains T cell activation initiated through the TCR. However, recently it has become clear that T cell immune responses are a result of a balance between stimulatory and inhibitory signals. Cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) is a cell surface molecule that is expressed nearly exclusively on CD4(+) and CD8(+) T cells. Investigation into the role of CTLA-4 in the regulation of T cell immune responses has revealed that CTLA-4 is a very important molecule involved in the maintenance of T cell homeostasis. In the present review, evidence for the proposed inhibitory role of CTLA-4 is examined and a model suggesting a role for CTLA-4 in both early and late stages of T cell activation is presented.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 92 条
[1]   THE YIN AND YANG OF T-CELL COSTIMULATION [J].
ALLISON, JP ;
KRUMMEL, MF .
SCIENCE, 1995, 270 (5238) :932-933
[2]   Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves disease and Hashimoto's thyroiditis) in the Japanese population [J].
Awata, T ;
Kurihara, S ;
Iitaka, M ;
Takei, S ;
Inoue, I ;
Ishii, C ;
Negishi, K ;
Izumida, T ;
Yoshida, Y ;
Hagura, R ;
Kuzuya, N ;
Kanazawa, Y ;
Katayama, S .
DIABETES, 1998, 47 (01) :128-129
[3]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[4]  
Balzano C, 1992, Int J Cancer Suppl, V7, P28
[5]  
Bluestone JA, 1997, J IMMUNOL, V158, P1989
[6]   A THEORY OF SELF-NONSELF DISCRIMINATION [J].
BRETSCHER, P ;
COHN, M .
SCIENCE, 1970, 169 (3950) :1042-+
[7]   THE 2-SIGNAL MODEL OF LYMPHOCYTE-ACTIVATION 21 YEARS LATER [J].
BRETSCHER, P .
IMMUNOLOGY TODAY, 1992, 13 (02) :74-76
[8]   A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY - CTLA-4 [J].
BRUNET, JF ;
DENIZOT, F ;
LUCIANI, MF ;
ROUXDOSSETO, M ;
SUZAN, M ;
MATTEI, MG ;
GOLSTEIN, P .
NATURE, 1987, 328 (6127) :267-270
[9]   Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH4-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70 [J].
Calvo, CR ;
Amsen, D ;
Kruisbeek, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1645-1653
[10]   Thymocyte development is normal in CTLA-4-deficient mice [J].
Chambers, CA ;
Cado, D ;
Truong, T ;
Allison, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9296-9301